METABOLIC SYNDROME AND CLINICAL OUTCOMES IN A SAMPLE OF EGYPTIAN PATIENTS INFECTED WITH COVID-19
Daif, M., Saleh, A., Ibraheem, T. (2023). METABOLIC SYNDROME AND CLINICAL OUTCOMES IN A SAMPLE OF EGYPTIAN PATIENTS INFECTED WITH COVID-19. EKB Journal Management System, 74(3), 747-756. doi: 10.21608/asmj.2023.321835
Marwa sayed Daif; Amr Mahmoud Mohamed Abd El -Hady Saleh; Tamer Mohamed Ibraheem. "METABOLIC SYNDROME AND CLINICAL OUTCOMES IN A SAMPLE OF EGYPTIAN PATIENTS INFECTED WITH COVID-19". EKB Journal Management System, 74, 3, 2023, 747-756. doi: 10.21608/asmj.2023.321835
Daif, M., Saleh, A., Ibraheem, T. (2023). 'METABOLIC SYNDROME AND CLINICAL OUTCOMES IN A SAMPLE OF EGYPTIAN PATIENTS INFECTED WITH COVID-19', EKB Journal Management System, 74(3), pp. 747-756. doi: 10.21608/asmj.2023.321835
Daif, M., Saleh, A., Ibraheem, T. METABOLIC SYNDROME AND CLINICAL OUTCOMES IN A SAMPLE OF EGYPTIAN PATIENTS INFECTED WITH COVID-19. EKB Journal Management System, 2023; 74(3): 747-756. doi: 10.21608/asmj.2023.321835

METABOLIC SYNDROME AND CLINICAL OUTCOMES IN A SAMPLE OF EGYPTIAN PATIENTS INFECTED WITH COVID-19

Ain Shams Medical Journal
Volume 74, Issue 3, September 2023, Page 747-756  XML PDF (332.12 K)
Document Type: Original Article
DOI: 10.21608/asmj.2023.321835
View on SCiNiTO View on SCiNiTO
Authors
Marwa sayed Daif email 1; Amr Mahmoud Mohamed Abd El -Hady Salehorcid 2; Tamer Mohamed Ibraheem3
1Department of Chest, Faculty of Medicine, Ain shams University, Cairo, Egypt.
2Department of Internal medicine, Ain Shams University, Cairo, Egypt.
3Department of Chest, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Abstract
Obesity, diabetes, and hypertension are the three main components of the metabolic syndrome and risk factors for developing severe COVID-19 infection. The pro-inflammatory state of metabolic syndrome may be responsible for associated complications of COVID-19. Methodology: We conducted a retrospective cross-sectional study in Ain Shams University Isolation Hospital. A total number of 101 patients were recruited during the period from June 2021 to December 2021 , and they were divided into two groups based on whether they had the metabolic syndrome or not.
Results: The majority of the admitted patients with COVID-19 were obese class I with mean = 34.72 kg/m2, and 57.4% of them were males. 59.6% of patients with metabolic syndrome had hypoxia in comparison to 38.9% of non metabolic syndrome patients who had hypoxia. They were also more vulnerable for admission in ICU than non metabolic syndrome patients , 38 (80.9%) vs 28 (51.9%) respectively. We found also statistically significant difference between patients with metabolic syndrome and non metabolic syndrome patients regarding medications and the need to receive methyl prednisolone and tocilizumab to suppress the cytokine storm, (36.2% )versus (3.7 % ) , (21.3 %) versus ( 1.9 %),(p value =0.01 ) and (p value =0.02 ) respectively. Conclusion: Metabolic syndrome is a strong risk factor for hospitalization and morbidity in a global population of hospitalized patients with COVID-19.
Keywords
COVID; 19 and Met S
Statistics
Article View: 50
PDF Download: 59